Knight Initiative News

Technology for reading signals directly from the brain developed by Stanford Bio-X scientists could provide a way for people with movement disorders to communicate.

A look at where research stands on some of the most devastating brain diseases.

Engineer Krishna Shenoy, PhD, and graduate student (and then postdoctoral fellow) Paul Nuyujukian, MD, PhD, have updated the algorithms for how they translate the brain signals into typing, which they tested in a series of studies.

We discovered that this impairment in regulation of Miro may actually underlie both familial (inherited) and sporadic (not inherited, or unknown family tree) forms of Parkinson’s disease.

Taking breaks—from naps to sabbaticals—can help us to refocus and recharge

Glaucoma, which affects nearly 70 million people worldwide, is caused by excessive pressure on the optic nerve — essentially the same kind of damage relieved by the manipulations in Andy Huberman’s study of restoration of vision in living mammals.

Parkinson’s disease, the second-leading neurodegenerative disorder after Alzheimer’s disease, affects one in every 60-70 Americans age 65 or older.

Intracellular defects that lead to cells’ failure to decommission faulty “power packs” known as mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.

In a new study in Nature Neuroscience, Ada Eban-Rothschild, PhD, Luis de Lecea, PhD, and their fellow Stanford neuroscientists identified a brain circuit that’s indispensable to the sleep-wake cycle as well as a key component of the reward system.

The 2016 Antonio Champalimaud Vision Award recognises ground-breaking work that has illuminated our understanding of the way in which our eyes send signals to the appropriate areas of the brain. This work may offer hope of fighting vision disorders by mea

Inhibiting the firing of nerve cells in a brain area long known to guide goal-directed behavior makes mice build nests and fall asleep, a new study shows. Stimulating the circuit roused the mice and kept them awake.

The study is designed to collect neurophysiological and psychological information from women faced with a breast cancer diagnosis and many treatment decisions.

For years, science-fiction moviemakers have been making us fear the bad things that artificially intelligent machines might do to their human creators. But for the next decade or two, our biggest concern is more likely to be that robots will take away our

Alice Ting's lab bustles with students working on projects relating to technologies for studying living cells in exacting molecular detail.

Three scientists discuss their pioneering discoveries about neuroplasticity, the brain's remarkable capacity to change throughout our lifetimes. For their research, Eve Marder, Michael Merzenich and Carla Shatz were named the 2016 Kavli Prize laureates in

The first research paper to describe a new phenomenon gets all the glory. A high profile publication. A great line on the scientist’s CV. Another step toward tenure.
What about the paper that verifies or fails to verify the phenomenon? That researcher ra

The 2016 Kavli Prize laureates discuss the brain's remarkable capacity for change and how that is causing us to rethink human potential.

The early stages of Alzheimer disease is marked by the wholesale destruction of synapses — junctions where neurons relay impulses from one cell to the next. As the condition progresses, whole nerve cells and even entire nerve circuits in the brain start t

In a Q&A, the neuroscientist discusses the reasons for continued basic and clinical research on an illegal drug scientists call 3,4-methylenedioxymethamphetamine, or MDMA, and partiers call Ecstasy.

Morphine and similar drugs are the world’s most widely used painkillers. But they’re also dangerous and addictive. A new compound may be able to safely provide the same analgesia as morphine.